Evidence of Clinically Meaningful Drug–Drug Interaction With Concomitant Use of Colchicine and Clarithromycin

被引：0
|
作者：
Lorenzo Villa Zapata
Philip D. Hansten
John R. Horn
Richard D. Boyce
Sheila Gephart
Vignesh Subbian
Andrew Romero
Daniel C. Malone
机构：
[1] University of Colorado,Skaggs School of Pharmacy and Pharmaceutical Sciences, Center for Pharmaceutical Outcomes Research
[2] University of Washington,School of Pharmacy
[3] University of Washington,Department of Pharmacy Practice, School of Pharmacy and Associate Director, Pharmacy Services UW Medicine
[4] University of Pittsburgh,Department of Biomedical Informatics, School of Medicine
[5] The University of Arizona,Community and Health Systems Science, College of Nursing
[6] The University of Arizona,Department of Biomedical Engineering and Department of Systems and Industrial Engineering, College of Engineering
[7] Banner University Medical Center,Department of Pharmacy
[8] University of Utah,Department of Pharmacotherapy, College of Pharmacy
来源：
Drug Safety | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：661 / 668
页数：7
相关论文
共 50 条
  • [1] Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin
    Zapata, Lorenzo Villa
    Hansten, Philip D.
    Horn, John R.
    Boyce, Richard D.
    Gephart, Sheila
    Subbian, Vignesh
    Romero, Andrew
    Malone, Daniel C.
    DRUG SAFETY, 2020, 43 (07) : 661 - 668
  • [2] Colchicine and clarithromycin drug interaction
    Reactions Weekly, 2020, 1800 (1) : 5 - 5
  • [3] Carbamazepine and clarithromycin:: a clinically relevant drug interaction
    Gelisse, P.
    Hillaire-Buys, D.
    Halaili, E.
    Jean-Pastor, M. -J.
    Vespignan, H.
    Coubes, P.
    Crespel, A.
    REVUE NEUROLOGIQUE, 2007, 163 (11) : 1096 - 1099
  • [4] Two probable cases of serious drug interaction between clarithromycin and colchicine
    Cheng, VCC
    Ho, PL
    Yuen, KY
    SOUTHERN MEDICAL JOURNAL, 2005, 98 (08) : 811 - 813
  • [5] Drug interaction alert override rates in the Meaningful Use era No evidence of progress
    Bryant, A. D.
    Fletcher, G. S.
    Payne, T. H.
    APPLIED CLINICAL INFORMATICS, 2014, 5 (03): : 802 - 813
  • [6] Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus
    Leino, Abbie D.
    Emoto, Chie
    Fukuda, Tsuyoshi
    Privitera, Michael
    Vinks, Alexander A.
    Alloway, Rita R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (10) : 2944 - 2948
  • [7] Absence of a clinically relevant drug-drug interaction between odanacatib and digoxin after concomitant administration
    Stoch, S. Aubrey
    Witter, Rose
    Hreniuk, David
    Liu, Chengcheng
    Zajic, Stefan
    Mehta, Anish
    Brandquist, Christine
    Dempsey, Cynthia
    DeGroot, Bruce
    Stypinski, Daria
    Denker, Andrew
    Wagner, John A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (08) : 688 - 692
  • [8] The determine of possible drug interaction of clarithromycin
    Ceylan, Cengizhan
    Kocberber, Emine Karatas
    Taner, Neda
    Berk, Barkin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (05) : 1341 - 1341
  • [9] Paroxetine-clarithromycin: a drug-drug interaction to highlight!
    Bakirci, S.
    Vigier, C.
    Bernier-Lahaie, M.
    Serfaty, R.
    Rocher, F.
    Spreux, A.
    Drici, M. D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 70 - 70
  • [10] SIGNIFICANT DRUG-DRUG INTERACTION BETWEEN ZOLPIDEM AND CLARITHROMYCIN
    Lee, Y. J.
    Byeon, J. Y.
    Kim, S. H.
    Kim, Y. H.
    Lee, H. J.
    Lee, Y.
    Kim, D. H.
    Lim, H. J.
    Jang, C. G.
    Lee, S. Y.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E138 - E138
12345